INVO Fertility Q2 revenue rises 17% to $2.2 million; net income $0.9 million
INVO Fertility reported second-quarter 2026 revenue of $2,175,485, up 17% from $1,863,654 a year earlier, mainly due to the February 2026 Family Beginnings acquisition. The company swung to net income of $888,740 from a net loss of $3,618,969, but that result includes an approximately $2.5 million remeasurement gain tied to the Birmingham clinic acquisition, while Adjusted EBITDA was a loss of $1,032,660 versus $587,229 a year earlier.
Key points
- Q2 2026 revenue was $2,175,485 versus $1,863,654 in Q2 2025, an increase of 17%.
- Net income was $888,740 versus a net loss of $3,618,969, including an approximately $2.5 million gain on remeasurement related to the Birmingham acquisition.
- Adjusted EBITDA was $(1,032,660) versus $(587,229) in Q2 2025.
- Cash was $3.7 million at June 30, 2026.
The filing
Written by AI on Nov 9, 2026, 10:08 AM ET, from this filing only. Written later: this filing was briefed after the fact, when past filings were added to the site, so the brief may be read with hindsight; the filing itself is the record of what was known on August 17, 2026.
Briefs are written by AI from the filing text and can contain mistakes — open the filing before acting on anything. Impact (1-5) and tone are the AI's reading of the filing for shareholders, not a price forecast. Not investment advice.